Bluejay Diagnostics annual r&d spending
2020
2021
2022
2023
2024
2025
Bluejay Diagnostics R&D Spending Growth & History (BJDX)
Bluejay Diagnostics's r&d spending was $3.0M for fiscal 2025.
View full Bluejay Diagnostics company overviewBluejay Diagnostics annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.0M | −$425,223 | −12.25% |
| 2024 | 2024-12-31 | $3.5M | −$2.2M | −39.25% |
| 2023 | 2023-12-31 | $5.7M | $1.6M | +37.63% |
| 2022 | 2022-12-31 | $4.2M | $3.0M | +261.70% |
| 2021 | 2021-12-31 | $1.1M | $620,702 | +117.72% |
| 2020 | 2020-12-31 | $527,253 | — | — |
Bluejay Diagnostics quarterly r&d spending
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.4M | $547,910 | +61.57% |
| Q1 2026 | 2026-03-31 | $811,837 | $27,037 | +3.45% |
| Q4 2025 | 2025-12-31 | $586,144 | $33,399 | +6.04% |
| Q3 2025 | 2025-09-30 | $785,608 | $233,953 | +42.41% |
| Q2 2025 | 2025-06-30 | $889,896 | −$142,578 | −13.81% |
| Q1 2025 | 2025-03-31 | $784,800 | −$549,997 | −41.20% |
| Q4 2024 | 2024-12-31 | $552,745 | −$733,706 | −57.03% |
| Q3 2024 | 2024-09-30 | $551,655 | −$845,663 | −60.52% |
| Q2 2024 | 2024-06-30 | $1.0M | −$643,782 | −38.41% |
| Q1 2024 | 2024-03-31 | $1.3M | −$19,752 | −1.46% |
| Q4 2023 | 2023-12-31 | $1.3M | −$34,996 | −2.65% |
| Q3 2023 | 2023-09-30 | $1.4M | $17,653 | +1.28% |
| Q2 2023 | 2023-06-30 | $1.7M | $919,973 | +121.64% |
| Q1 2023 | 2023-03-31 | $1.4M | $659,792 | +94.97% |
| Q4 2022 | 2022-12-31 | $1.3M | $866,194 | +190.27% |
| Q3 2022 | 2022-09-30 | $1.4M | $937,138 | +211.77% |
| Q2 2022 | 2022-06-30 | $756,283 | $530,291 | +234.65% |
| Q1 2022 | 2022-03-31 | $694,757 | $670,574 | +2772.91% |
| Q4 2021 | 2021-12-31 | $455,253 | — | — |
| Q3 2021 | 2021-09-30 | $442,527 | $439,804 | +16151.45% |
| Q2 2021 | 2021-06-30 | $225,992 | — | — |
| Q1 2021 | 2021-03-31 | $24,183 | — | — |
| Q3 2020 | 2020-09-30 | $2,723 | — | — |
Bluejay Diagnostics r&d spending trends
Over the last five fiscal years, Bluejay Diagnostics's r&d spending increased from $527,253 to $3.0M, a change of $2.5M. The latest reported quarter, Q2 2026, shows $1.4M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bluejay Diagnostics source filings ↗